{"id":2675,"date":"2021-10-18T08:46:27","date_gmt":"2021-10-18T06:46:27","guid":{"rendered":"https:\/\/www.socesfar.es\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-1-2020\/"},"modified":"2021-10-19T16:01:12","modified_gmt":"2021-10-19T14:01:12","slug":"actualidad-en-farmacologia-y-terapeutica-vol-18-no-1-2020","status":"publish","type":"revista","link":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-1-2020\/","title":{"rendered":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 18, n\u00ba 1, 2020"},"content":{"rendered":"\n<p>T<strong>erapias biol\u00f3gicas en asma<br\/><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/09\/AFTV18N1WEB.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 18, n\u00ba 1, 2020<\/a><\/strong><\/p>\n\n<h4 class=\"wp-block-heading\"><\/h4>\n\n<h4 class=\"wp-block-heading\"><\/h4>\n\n<h4 class=\"wp-block-heading\"><strong>\u00cdndice<\/strong><\/h4>\n\n<ul class=\"wp-block-list\"><li><strong>Editorial del Presidente.<\/strong><a href=\"https:\/\/www.socesfar.es\/images\/joomlart\/revista\/2020\/Editorial del Presidente La SEF ante nuevos retos.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"> <\/a><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/09\/Editorial-del-Presidente-La-SEF-ante-nuevos-retos.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">La SEF ante nuevos retos<\/a><\/li><li><strong>Editorial del Director.<\/strong><a href=\"https:\/\/www.socesfar.es\/images\/joohttps:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/09\/Editorial-del-Director-Michael-Berridge-y-el-calcio.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"> <\/a><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/09\/Editorial-del-Director-Michael-Berridge-y-el-calcio.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Michael Berridge y el calcio<\/a><\/li><li><strong>Art\u00edculo de opini\u00f3n.<\/strong><a href=\"https:\/\/www.socesfar.es\/images\/joomlart\/revista\/2020\/Desabastecimiento y medicamentos sin interes comercial.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"> <\/a><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/09\/Desabastecimiento-y-medicamentos-sin-interes-comercial.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Desabastecimiento y medicamentos sin inter\u00e9s comercial<\/a><\/li><li><strong>Investigaci\u00f3n traslacional.<\/strong><a href=\"https:\/\/www.socesfar.es\/images\/joomlart\/revista\/2020\/Atrapadores de glutamato plasmatico en ictus.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"> <\/a><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/09\/Atrapadores-de-glutamato-plasmatico-en-ictus.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Atrapadores de glutamato plasm\u00e1tico en ictus isqu\u00e9mico<\/a><\/li><li><strong>Revisiones en Farmacoterapia<\/strong><ul><li><a href=\"https:\/\/www.socesfar.es\/images\/joomlart\/revista\/2020\/Terapias biologicas en asma.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">T<\/a><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/09\/Terapias-biologicas-en-asma.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">erapias biol\u00f3gicas en asma<\/a><\/li><li><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/09\/Probioticos-paraprobioticos-y-obesidad-infantil.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Probi\u00f3ticos, pararprobi\u00f3ticos y obesidad infantil<\/a><\/li><\/ul><\/li><li><strong>Casos farmacoter\u00e1picos. <\/strong><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/09\/Sintomas-musculoesqueleticos-asociados-a-inhibidores-de-aromatasa.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">S\u00edntomas musculoesquel\u00e9ticos asociados a inhibidores de aromatasa<\/a><\/li><li><strong>El f\u00e1rmaco, la palabra y la poes\u00eda<\/strong><ul><li><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/09\/Paradigmas.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Paradigmas<\/a><\/li><li>Del &#8220;Recetario Po\u00e9tico de los Estudiantes de Medicina de la UAM&#8221;<\/li><\/ul><\/li><li><strong>La SEF informa<\/strong><ul><li>La SEF informa<\/li><li>Hazte socio de la SEF<\/li><\/ul><\/li><li><strong>Normas para los autores<\/strong><\/li><\/ul>","protected":false},"featured_media":0,"template":"","categoria_revista":[65],"class_list":["post-2675","revista","type-revista","status-publish","hentry","categoria_revista-2020-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 18, n\u00ba 1, 2020 - Sociedad Espa\u00f1ola de Farmacolog\u00eda<\/title>\n<meta name=\"description\" content=\"Terapias biol\u00f3gicas en asma. La SEF ante nuevos retos. Michael Berridge y el calcio. Desabastecimiento y medicamentos sin inter\u00e9s comercial.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-1-2020\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 18, n\u00ba 1, 2020 - Sociedad Espa\u00f1ola de Farmacolog\u00eda\" \/>\n<meta property=\"og:description\" content=\"Terapias biol\u00f3gicas en asma. La SEF ante nuevos retos. Michael Berridge y el calcio. Desabastecimiento y medicamentos sin inter\u00e9s comercial.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-1-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\" \/>\n<meta property=\"article:modified_time\" content=\"2021-10-19T14:01:12+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@Socesfar\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-1-2020\/\",\"url\":\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-1-2020\/\",\"name\":\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 18, n\u00ba 1, 2020 - Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"isPartOf\":{\"@id\":\"https:\/\/www.socesfar.es\/en\/#website\"},\"datePublished\":\"2021-10-18T06:46:27+00:00\",\"dateModified\":\"2021-10-19T14:01:12+00:00\",\"description\":\"Terapias biol\u00f3gicas en asma. La SEF ante nuevos retos. Michael Berridge y el calcio. Desabastecimiento y medicamentos sin inter\u00e9s comercial.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-1-2020\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-1-2020\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-1-2020\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.socesfar.es\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Revistas\",\"item\":\"https:\/\/www.socesfar.es\/en\/revistas\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 18, n\u00ba 1, 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.socesfar.es\/en\/#website\",\"url\":\"https:\/\/www.socesfar.es\/en\/\",\"name\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.socesfar.es\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.socesfar.es\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.socesfar.es\/en\/#organization\",\"name\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"url\":\"https:\/\/www.socesfar.es\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.socesfar.es\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/07\/logo-socesfar-02.png\",\"contentUrl\":\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/07\/logo-socesfar-02.png\",\"width\":383,\"height\":63,\"caption\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\"},\"image\":{\"@id\":\"https:\/\/www.socesfar.es\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/Socesfar\",\"https:\/\/www.linkedin.com\/company\/socesfar\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 18, n\u00ba 1, 2020 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","description":"Terapias biol\u00f3gicas en asma. La SEF ante nuevos retos. Michael Berridge y el calcio. Desabastecimiento y medicamentos sin inter\u00e9s comercial.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-1-2020\/","og_locale":"en_US","og_type":"article","og_title":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 18, n\u00ba 1, 2020 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","og_description":"Terapias biol\u00f3gicas en asma. La SEF ante nuevos retos. Michael Berridge y el calcio. Desabastecimiento y medicamentos sin inter\u00e9s comercial.","og_url":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-1-2020\/","og_site_name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","article_modified_time":"2021-10-19T14:01:12+00:00","twitter_card":"summary_large_image","twitter_site":"@Socesfar","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-1-2020\/","url":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-1-2020\/","name":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 18, n\u00ba 1, 2020 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","isPartOf":{"@id":"https:\/\/www.socesfar.es\/en\/#website"},"datePublished":"2021-10-18T06:46:27+00:00","dateModified":"2021-10-19T14:01:12+00:00","description":"Terapias biol\u00f3gicas en asma. La SEF ante nuevos retos. Michael Berridge y el calcio. Desabastecimiento y medicamentos sin inter\u00e9s comercial.","breadcrumb":{"@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-1-2020\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-1-2020\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-1-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.socesfar.es\/en\/"},{"@type":"ListItem","position":2,"name":"Revistas","item":"https:\/\/www.socesfar.es\/en\/revistas\/"},{"@type":"ListItem","position":3,"name":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 18, n\u00ba 1, 2020"}]},{"@type":"WebSite","@id":"https:\/\/www.socesfar.es\/en\/#website","url":"https:\/\/www.socesfar.es\/en\/","name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","description":"","publisher":{"@id":"https:\/\/www.socesfar.es\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.socesfar.es\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.socesfar.es\/en\/#organization","name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","url":"https:\/\/www.socesfar.es\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.socesfar.es\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/07\/logo-socesfar-02.png","contentUrl":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/07\/logo-socesfar-02.png","width":383,"height":63,"caption":"Sociedad Espa\u00f1ola de Farmacolog\u00eda"},"image":{"@id":"https:\/\/www.socesfar.es\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/Socesfar","https:\/\/www.linkedin.com\/company\/socesfar\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista\/2675","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista"}],"about":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/types\/revista"}],"version-history":[{"count":3,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista\/2675\/revisions"}],"predecessor-version":[{"id":2694,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista\/2675\/revisions\/2694"}],"wp:attachment":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/media?parent=2675"}],"wp:term":[{"taxonomy":"categoria_revista","embeddable":true,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/categoria_revista?post=2675"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}